Notably, these two conditions are associated with increased levels of C-reactive protein, interleukin-6, plasmin-antiplasmin complex, factor VII, and factor VIII, which by inducing inflammation and hypercoagulability may further promote atherosclerosis progression and thrombosis [28,29]. The gene discussed is IL6; the disease is thrombophilia.